NewsBenzingaBMO资本将Ionis Pharmaceuticals评级上调至“跑赢大盘”，并将目标价上调至66美元 BMO资本将Ionis Pharmaceuticals评级上调至“跑赢大盘”，并将目标价上调至66美元 Benzinga 2026.10.22 09:35 (GMT+0) Open on Benzinga Other news TTM Technologies Q3 2026 Earnings Call Transcript TD Cowen Maintains Buy on Abbott Laboratories, Lowers Price Target to $118 WeTouch Technology Partners With Ruilan International To Develop AI-Powered Senior Care Solutions Across China JP Morgan Downgrades Qiagen to Neutral, Lowers Price Target to $52 American Airlines CFO Says Hope To Finalize Widebody Order This Year TD Cowen Reiterates Hold on AT&T, Maintains $33 Price Target
WeTouch Technology Partners With Ruilan International To Develop AI-Powered Senior Care Solutions Across China
